A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence.
英國一家生物技術初創(chuàng)企業(yè)獲得了由默沙東全球健康創(chuàng)新基金(MSD GHIF)領投的1400萬美元早期融資，用于開發(fā)人工智能“經得起未來考驗”的疫苗。
您已閱讀9%（391字），剩余91%（4073字）包含更多重要信息，訂閱以繼續(xù)探索完整內容，并享受更多專屬服務。